339 related articles for article (PubMed ID: 17694962)
1. An impedance-controlled system for endometrial ablation: five-year follow-up of 107 patients.
Gallinat A
J Reprod Med; 2007 Jun; 52(6):467-72. PubMed ID: 17694962
[TBL] [Abstract][Full Text] [Related]
2. NovaSure impedance controlled system for endometrial ablation: three-year follow-up on 107 patients.
Gallinat A
Am J Obstet Gynecol; 2004 Nov; 191(5):1585-9. PubMed ID: 15547528
[TBL] [Abstract][Full Text] [Related]
3. NovaSure impedance controlled endometrial ablation: long-term follow-up results.
Fulop T; Rákóczi I; Barna I
J Minim Invasive Gynecol; 2007; 14(1):85-90. PubMed ID: 17218236
[TBL] [Abstract][Full Text] [Related]
4. Endometrial ablation with NovaSure GEA, a pilot study.
Busund B; Erno LE; Grønmark A; Istre O
Acta Obstet Gynecol Scand; 2003 Jan; 82(1):65-8. PubMed ID: 12580843
[TBL] [Abstract][Full Text] [Related]
5. Office endometrial ablation with local anesthesia using the HydroThermAblator system: Comparison of outcomes in patients with submucous myomas with those with normal cavities in 246 cases performed over 5(1/2) years.
Glasser MH; Heinlein PK; Hung YY
J Minim Invasive Gynecol; 2009; 16(6):700-7. PubMed ID: 19896596
[TBL] [Abstract][Full Text] [Related]
6. Use of the NovaSure Impedance Controlled Endometrial Ablation System in patients with intracavitary disease: 12-month follow-up results of a prospective, single-arm clinical study.
Sabbah R; Desaulniers G
J Minim Invasive Gynecol; 2006; 13(5):467-71. PubMed ID: 16962534
[TBL] [Abstract][Full Text] [Related]
7. Five-year follow up of a randomised controlled trial comparing NovaSure and ThermaChoice endometrial ablation.
Kleijn JH; Engels R; Bourdrez P; Mol BW; Bongers MY
BJOG; 2008 Jan; 115(2):193-8. PubMed ID: 17617188
[TBL] [Abstract][Full Text] [Related]
8. NovaSure impedance-controlled system for endometrial ablation.
Gallinat A; Nugent W
J Am Assoc Gynecol Laparosc; 2002 Aug; 9(3):283-9. PubMed ID: 12101323
[TBL] [Abstract][Full Text] [Related]
9. A randomised controlled trial comparing the Cavaterm endometrial ablation system with the Nd:YAG laser for the treatment of dysfunctional uterine bleeding.
Hawe J; Abbott J; Hunter D; Phillips G; Garry R
BJOG; 2003 Apr; 110(4):350-7. PubMed ID: 12699795
[TBL] [Abstract][Full Text] [Related]
10. Cavaterm thermal balloon endometrial ablation versus hysteroscopic endometrial resection to treat menorrhagia: the French, multicenter, randomized study.
Brun JL; Raynal J; Burlet G; Galand B; Quéreux C; Bernard P
J Minim Invasive Gynecol; 2006; 13(5):424-30. PubMed ID: 16962526
[TBL] [Abstract][Full Text] [Related]
11. The effect of levonorgestrel intrauterine system on uterine myomas: a 1-year follow-up study.
Gunes M; Ozdegirmenci O; Kayikcioglu F; Haberal A; Kaplan M
J Minim Invasive Gynecol; 2008; 15(6):735-8. PubMed ID: 18971138
[TBL] [Abstract][Full Text] [Related]
12. Second-generation endometrial ablation treatment: Novasure.
Bongers MY
Best Pract Res Clin Obstet Gynaecol; 2007 Dec; 21(6):989-94. PubMed ID: 17490913
[TBL] [Abstract][Full Text] [Related]
13. One-Year Follow-Up Results of a Multicenter, Single-Arm, Objective Performance Criteria-Controlled International Clinical Study of the Safety and Efficacy of the Minerva Endometrial Ablation System.
Laberge P; Garza-Leal J; Fortin C; Sabbah R; Fulop T; Pásztor N; Bacsko G
J Minim Invasive Gynecol; 2015; 22(7):1169-77. PubMed ID: 26072204
[TBL] [Abstract][Full Text] [Related]
14. [Long-term effect on radiofrequency heat-coagulation endometrial ablation in the treatment of anovulatory dysfunctional uterine bleeding].
Yin GP; Li J; Zhu TY; Chen M; Yang SJ; Zhao XL
Zhonghua Fu Chan Ke Za Zhi; 2011 Sep; 46(9):664-8. PubMed ID: 22176990
[TBL] [Abstract][Full Text] [Related]
15. Resectoscopic surgery may be an alternative to hysterectomy in high-risk women with atypical endometrial hyperplasia.
Edris F; Vilos GA; Al-Mubarak A; Ettler HC; Hollett-Caines J; Abu-Rafea B
J Minim Invasive Gynecol; 2007; 14(1):68-73. PubMed ID: 17218233
[TBL] [Abstract][Full Text] [Related]
16. [Thermal balloon endometrial ablation for dysfunctional uterine bleeding: technical aspects and results. A prospective cohort study of 152 cases].
Kdous M; Jacob D; Gervaise A; Risk E; Sauvanet E
Tunis Med; 2008 May; 86(5):473-8. PubMed ID: 19469303
[TBL] [Abstract][Full Text] [Related]
17. [Long-term follow-up after endometrial ablation. A questionnaire study on bleedings, hormone treatment and surgery].
Krogh RA; Lauszus FF; Rasmussen KL
Ugeskr Laeger; 2009 Aug; 171(34):2371-6. PubMed ID: 19732517
[TBL] [Abstract][Full Text] [Related]
18. Comparison of the long-term histopathologic and morphologic changes after endometrial rollerball ablation and resection: a prospective randomized trial.
Onoglu A; Taskin O; Inal M; Sadik S; Simsek M; Akar M; Kursun S; Mendilcioglu I; Postaci H; Ispahi C
J Minim Invasive Gynecol; 2007; 14(1):39-42. PubMed ID: 17218227
[TBL] [Abstract][Full Text] [Related]
19. Novasure impedance control system versus microwave endometrial ablation for the treatment of dysfunctional uterine bleeding: a double-blind, randomized controlled trial.
Athanatos D; Pados G; Venetis CA; Stamatopoulos P; Rousso D; Tsolakidis D; Stamatopoulos CP; Tarlatzis BC
Clin Exp Obstet Gynecol; 2015; 42(3):347-51. PubMed ID: 26152008
[TBL] [Abstract][Full Text] [Related]
20. Improved premenstrual syndrome symptoms after NovaSure endometrial ablation.
Lukes AS; McBride RJ; Herring AH; Fried M; Sherwani A; Dell D
J Minim Invasive Gynecol; 2011; 18(5):607-11. PubMed ID: 21872168
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
